Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Cutter

Showing results (151-160 of 333) with videos related to

Pageof 34
Sort By:
Annals of Clinical and Translational Neurology|February 28, 2023
Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD)Itay Lotan, Gabriela Romanow, Rebecca Salky, et al.
Frontiers in Neurology|July 11, 2022
The Potential for EBV Vaccines to Prevent Multiple SclerosisPeter A Maple, Alberto Ascherio, Jeffrey I Cohen, et al.
Frontiers in Neurology|July 5, 2022
Transcallosal and Corticospinal White Matter Disease and Its Association With Motor Impairment in Multiple SclerosisKeejin Yoon, Derek B Archer, Margareta A Clarke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 6, 2011
Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosisFlavia Nelson, Sushmita Datta, Nereyda Garcia, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 22, 2025
Seeking optimal repeated fluid biomarker assessments to enhance precision and statistical power in clinical trials: SLIM methodHiroko H Dodge, Liu Chen, Chao-Yi Wu, et al.
Therapeutic Advances in Neurological Disorders|July 15, 2021
A propensity-matched comparison of long-term disability worsening in patients with multiple sclerosis treated with dimethyl fumarate or fingolimodAmber Salter, Samantha Lancia, Gary Cutter, et al.
Neurology. Clinical Practice|June 23, 2022
Sources of Cannabis Information and Medical Guidance for Neurologic Use: NARCOMS Survey of People Living With Multiple SclerosisAmber Salter, Gary Cutter, Ruth Ann Marrie, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2014
A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosisRuth Ann Marrie, Nadia Reider, Jeffrey Cohen, et al.
European Journal of Neurology|August 25, 2021
Baseline characteristics and effects of fingolimod on cognitive performance in patients with relapsing-remitting multiple sclerosisDawn W Langdon, Davorka Tomic, Iris-Katharina Penner, et al.
International Journal of MS Care|January 17, 2022
A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple SclerosisAmber Salter, Robert J Fox, Gary Cutter, et al.
Pageof 34

Showing results (151-160 of 333) with videos related to

Sort By:
Pageof 34
Annals of Clinical and Translational Neurology|February 28, 2023
Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD)Itay Lotan, Gabriela Romanow, Rebecca Salky, et al.
Frontiers in Neurology|July 11, 2022
The Potential for EBV Vaccines to Prevent Multiple SclerosisPeter A Maple, Alberto Ascherio, Jeffrey I Cohen, et al.
Frontiers in Neurology|July 5, 2022
Transcallosal and Corticospinal White Matter Disease and Its Association With Motor Impairment in Multiple SclerosisKeejin Yoon, Derek B Archer, Margareta A Clarke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 6, 2011
Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosisFlavia Nelson, Sushmita Datta, Nereyda Garcia, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 22, 2025
Seeking optimal repeated fluid biomarker assessments to enhance precision and statistical power in clinical trials: SLIM methodHiroko H Dodge, Liu Chen, Chao-Yi Wu, et al.
Therapeutic Advances in Neurological Disorders|July 15, 2021
A propensity-matched comparison of long-term disability worsening in patients with multiple sclerosis treated with dimethyl fumarate or fingolimodAmber Salter, Samantha Lancia, Gary Cutter, et al.
Neurology. Clinical Practice|June 23, 2022
Sources of Cannabis Information and Medical Guidance for Neurologic Use: NARCOMS Survey of People Living With Multiple SclerosisAmber Salter, Gary Cutter, Ruth Ann Marrie, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2014
A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosisRuth Ann Marrie, Nadia Reider, Jeffrey Cohen, et al.
European Journal of Neurology|August 25, 2021
Baseline characteristics and effects of fingolimod on cognitive performance in patients with relapsing-remitting multiple sclerosisDawn W Langdon, Davorka Tomic, Iris-Katharina Penner, et al.
International Journal of MS Care|January 17, 2022
A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple SclerosisAmber Salter, Robert J Fox, Gary Cutter, et al.
Pageof 34